Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:10 PM
Ignite Modification Date:
2025-12-24 @ 9:10 PM
NCT ID:
NCT03161704
Eligibility Criteria:
Exclusion Criteria:
* • Currently pregnant
* Current or past diagnosis of any malignancy (with the exception of non-melanoma skin cancer)
* Known to be HIV-positive
* Unable to give informed consent
* Unwillingness to have samples banked in Repository for future use
* Clinical evidence of active cervical infection
* Lupron (or other GRH agonist) therapy within the last 2 months (or Depo-Lupron within the last 4 months)
* Current use of estrogen or progestin (oral, transdermal, intrauterine or ring).
o Current use is defined as use in the index menstrual cycle (since the onset of the last menstrual period).
* Use of depo estrogen or progestin in last 3 months
* Current use of aromatase inhibitor
Inclusion Criteria:
* Women aged 18-44 scheduled to undergo gynecologic surgery (laparoscopy/laparotomy).
Indication for surgery can include: infertility, endometriosis, tubal ligation, lysis of adhesions, pelvic pain, hysterectomy (for benign condition), myomectomy, salpingo-oophorectomy, cystectomy, or diagnostic laparoscopy.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
44 Years
Study:
NCT03161704
Study Brief:
Protocol Section:
NCT03161704